A value analysis committee (VAC) is a multidisciplinary hospital or health-system committee that reviews and approves requests to purchase new products, equipment, devices, or supplies before they enter clinical or laboratory use. It is the standard governance gate US hospitals use to make sure a new purchase is clinically justified, safe, and cost-effective before it reaches a contract or a purchase order — and for a core-facility director, lab manager, or clinical-lab supervisor trying to bring in new equipment or a new supply line, it is usually the single biggest procedural hurdle between “we need this” and “it’s installed and validated.”
This guide covers what a VAC actually reviews, how the approval process runs end to end, who sits on the committee, and how to build a submission that survives the process on the first pass.
What a value analysis committee does
A VAC exists to replace ad hoc, single-department purchasing decisions with a structured, evidence-based review. Instead of one physician or one department head approving a new device or supply line on their own authority, the request goes through a standing committee that weighs three things together:
- Clinical or scientific value — does the product improve patient outcomes, safety, workflow, or (for a research/core facility) data quality and throughput, relative to what’s already in use?
- Cost — not just unit price, but total cost of ownership: consumables, service contracts, training, disposal, and any downstream cost the new product shifts elsewhere in the organization.
- Standardization — does introducing this product fragment the supply chain (a fourth vendor for a category three vendors already cover), or can an existing standardized product meet the need instead?
VACs sit inside the hospital’s broader supply chain and materials management function. Their scope typically covers medical/surgical supplies, capital equipment, purchased services, and — in academic medical centers and hospital-affiliated core facilities — laboratory instrumentation and reagents that cross from research into clinical or biobanking workflows.
The value analysis committee process, step by step
The exact workflow varies by institution, but most VAC processes follow the same sequence:
1. Request submission
The requesting department (a lab, a clinical unit, a core facility) submits a formal request, usually through an intake form or a value analysis software platform. A complete submission typically includes the clinical or scientific rationale, the product specification, comparable products already in use, a preliminary cost estimate, and the name of a physician or clinical champion willing to sponsor the request.
2. Triage and routing
Supply chain or value analysis staff screen the request for completeness and route it to the relevant sub-team — many hospitals run category-specific sub-committees (e.g., surgical services, laboratory, IT/informatics, capital equipment) that feed into a system-level VAC for final sign-off on higher-cost or cross-department items.
3. Clinical and technical review
Clinical stakeholders evaluate the product against current standards of care or laboratory practice: does it require new competency training, does it change a validated procedure, does it introduce a new failure mode or safety risk. For laboratory and diagnostic equipment this step often overlaps with, but does not replace, formal method or instrument validation.
4. Cost-benefit and value analysis
Supply chain and finance build the cost-benefit case: purchase price against an existing group purchasing organization (GPO) contract price, projected volume, consumable cost per test or per procedure, and any offsetting savings (reduced waste, fewer repeat tests, shorter procedure time). This is the step that gives the process its name — product value is measured, not assumed.
5. Trial or evaluation period
For many product categories, the committee authorizes a limited trial — a defined quantity or time period — before full approval, with feedback collected from end users on performance, ease of use, and any adverse events or near-misses.
6. Committee vote and standardization decision
The VAC votes to approve, reject, or approve with conditions (e.g., approved for one unit only, approved pending a lower price from the vendor, approved as a like-for-like replacement only). Approval frequently comes bundled with a standardization decision — committing the whole system to one vendor for that category going forward.
7. Contracting and onboarding
Once approved, the request moves to contracting: negotiating final pricing (often through or against an existing GPO agreement), vendor credentialing, and setting up the item in the purchasing system. Only after this step can the requesting department actually place a purchase order.
Who sits on a value analysis committee
VAC membership is deliberately cross-functional so no single interest dominates the decision. A typical roster includes:
- Supply chain / materials management — usually chairs the committee and owns the process, contracting, and GPO relationships.
- Physician and nursing representatives — provide the clinical case and sign off on patient-safety implications.
- Finance — validates the cost-benefit analysis and budget impact.
- Infection prevention — reviews anything with infection-control implications (single-use vs. reusable devices, sterilization requirements).
- Biomedical/clinical engineering — assesses equipment integration, maintenance burden, and compatibility with existing systems.
- Laboratory or core-facility leadership — represents diagnostic, research-support, or core-lab interests when the request touches instrumentation or reagents.
- Risk management and quality/regulatory staff — flag regulatory, liability, or accreditation implications.
Some health systems now run dedicated value analysis professionals as full-time staff rather than committee volunteers — a role formalized by the Association of Healthcare Value Analysis Professionals (AHVAP), which offers the CVAHP (Certified Value Analysis Healthcare Professional) credential and publishes standards of practice for the field.
Why this matters for lab managers and core-facility directors
Research core facilities and clinical laboratories inside a hospital or academic medical center are not exempt from the VAC process just because a purchase is grant-funded or research-driven — if the item is procured through the institution’s supply chain (which most capital equipment and recurring reagent orders are), it typically still has to clear value analysis, even when the requesting lab has its own budget authority to pay for it. This surprises researchers used to buying directly from a vendor with a purchase order and no further review.
Practical implications:
- Budget the time. A VAC cycle can take anywhere from a few weeks for a low-cost, non-standardizing item to several months for capital equipment that requires a trial period and a standardization vote.
- Build the business case before submitting. A request that arrives with a clear clinical/scientific rationale, a named champion, comparable-product context, and a realistic cost estimate moves faster than one that arrives as a bare product name.
- Expect a standardization conversation. If your institution already has an approved vendor in the same category, be ready to explain why the existing option doesn’t meet the need — “the incumbent product works for X but not Y” is a stronger submission than “I prefer this brand.”
- Coordinate with your GPO contract. Many VACs check group purchasing organization pricing before evaluating an off-contract vendor; see our guide to group purchasing organizations for research institutions for how that pricing relationship works.
- Vendor qualification is a separate, later step. VAC approval decides whether the product category and vendor are acceptable at all; it does not replace the vendor’s own qualification file. See vendor qualification process and vendor selection criteria for what happens after a vendor is approved.
Value analysis committee vs. related review bodies
It’s easy to conflate a VAC with other hospital or health-system committees that also touch purchasing decisions:
- Pharmacy and Therapeutics (P&T) Committee — the equivalent body for drugs and formulary decisions, not devices or supplies.
- Capital equipment committee — at some institutions this is a separate, higher-threshold body for large capital purchases; at others it’s a sub-committee that feeds into the VAC.
- Institutional Review Board (IRB) — reviews research involving human subjects for ethical and regulatory compliance; it has no role in whether a piece of lab equipment gets purchased.
- Purchasing/procurement department — executes the contract and purchase order after value analysis approval; it doesn’t make the clinical or cost-benefit judgment call itself.
Frequently asked questions
What is a hospital value analysis committee?
A hospital value analysis committee is the standing, multidisciplinary body that reviews requests for new medical products, equipment, and supplies against clinical value, cost, and standardization before they can be purchased through the hospital’s supply chain.
Why does my lab need value analysis committee approval for equipment we’re already budgeted to buy?
Having budget authority for a purchase and having supply-chain clearance to make it are two separate approvals. If the item is procured through the institution’s central purchasing system — which most capital equipment, reagents, and recurring supply orders are — it typically still needs to clear the VAC regardless of which budget pays for it.
How long does the value analysis process take?
It varies widely by institution and item complexity: low-cost, non-standardizing consumables can clear in a few weeks, while capital equipment or anything requiring a trial period and a system-wide standardization vote can take several months.
What should a value analysis request include?
A strong submission includes the clinical or scientific rationale, a product specification, a named physician or clinical champion, comparison against products already in use, and a realistic cost estimate covering total cost of ownership, not just unit price.
Is value analysis the same as vendor selection?
No. Value analysis decides whether a product category and cost profile are justified for the institution at all; vendor selection and qualification — evaluating which specific supplier to use and verifying they meet quality and regulatory standards — happen alongside or after VAC approval. See vendor selection criteria for that separate process.
